Early-stage lung cancer treatments evaluated in patients with breathing problems

April 10, 2012 By Caroline Arbanas
A CT image shows an early-stage lung tumor. A new clinical trial will evaluate whether a limited surgical procedure or a specialized type of radiation therapy is the best treatment for patients with early-stage lung cancer who also have breathing problems. Credit: JEFFREY BRADLEY, MD

(Medical Xpress) -- The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is seeking patients for a clinical study to determine the best treatment for patients with early-stage lung cancer who also have breathing problems.

Many patients with early-stage lung cancer have emphysema, pulmonary hypertension or other that limit their options.

The study focuses on patients with the most common type of lung cancer, non-small cell lung cancer. When it is diagnosed early, the standard treatment is . But the operation is especially risky for patients with poor lung function, who often have complications after surgery.

In the new trial, doctors will compare a type of radiation therapy, called stereotactic body radiation therapy, to a more limited surgical procedure. Rather than remove the entire section of the lung, surgeons will remove only a small portion, which may reduce complications after surgery.

Stereotactic body radiation therapy pinpoints high doses of radiation directly to the tumor, while reducing damage to surrounding tissues. It can also be delivered in just several treatments over seven to 10 days, compared to conventional radiation, where treatment is given over six to eight weeks.

Stereotactic body radiation therapy is the treatment of choice for patients with non-small cell lung cancer who are too frail for any surgery. But doctors don’t know whether it is better than the limited surgery for patients healthy enough for surgery but who have decreased lung function.

“Our hope is that doctors and patients will embrace this cutting-edge trial so we can clarify the optimal treatment for this group of higher-risk patients,” says study co-investigator Bryan F. Meyers, MD, chief of the Section of Thoracic Surgery. “For very frail patients, we have stereotactic body radiation therapy. For fit patients, surgery still dominates. This trial looks at people on the cusp for whom we don’t have certainty.” 

Nationwide, an estimated 420 patients will be enrolled in the trial, which is sponsored by the National Cancer Institute. Traves Crabtree, MD, assistant professor of surgery, is the local principal investigator of the study.

To be eligible, patients must have an early-stage (1A or selected 1B) non-small cell lung tumor and not received other cancer treatments.
Siteman Cancer Center was involved in an earlier trial of stereotactic body radiation therapy for early-stage non-small cell lung cancer in patients too frail for surgery.

“We have one of the largest U.S. experiences with stereotactic body radiation therapy for lung cancer,” says study co-investigator Jeffrey Bradley, MD, professor of radiation oncology. “It can eradicate lung tumors in 90-95 percent of patients with early-stage cancer, double that of conventional radiation therapy. And stereotactic therapy also appears to double the survival rate in these patients, compared to conventional radiation therapy. It’s definitely a major advance in treatment.”

Patients in the study will be randomly assigned to receive either three treatments of stereotactic body over seven to 10 days or the limited surgical procedure. Over the next five years, doctors will evaluate ’ survival rates and their quality of life after treatment. 

Explore further: Many lung cancer patients get radiation therapy that may not prolong their lives

More information: For more information about the study, call clinical nurse research coordinator, Jo Musick at (314) 747-0707.

Related Stories

Many lung cancer patients get radiation therapy that may not prolong their lives

February 13, 2012
A new study has found that many older lung cancer patients get treatments that may not help them live longer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest ...

SBRT provides better outcomes than surgery for cancer patients with common lung disease

February 16, 2012
Stereotactic body radiotherapy (SBRT) provides better overall survival rates than surgery for lung cancer patients with severe chronic obstructive pulmonary disease (COPD), a disease commonly associated with lung cancer, ...

Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009

July 6, 2011
New developments such as stereotactic ablative radiotherapy and improvements in surgical care in early-stage lung cancer have led to large survival gains for elderly Dutch patients, according to a population-based study presented ...

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.